Your browser doesn't support javascript.
loading
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience.
Özbalak, Murat; Salihoglu, Ayse; Soysal, Teoman; Karadogan, Ihsan; Paydas, Semra; Özdemir, Evren; Yildiz, Birol; Karadurmus, Nuri; Kaynar, Leylagül; Yagci, Münci; Özkocaman, Vildan; Topçuoglu, Pervin; Özcan, Muhit; Birtas, Elif; Göker, Hakan; Ferhanoglu, Burhan.
Afiliación
  • Özbalak M; Department of Internal Medicine, Division of Hematology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Salihoglu A; Department of Internal Medicine, Division of Hematology, Istanbul University Cerrahpasa, Istanbul, Turkey.
  • Soysal T; Department of Internal Medicine, Division of Hematology, Istanbul University Cerrahpasa, Istanbul, Turkey.
  • Karadogan I; Division of Hematology, Antalya Medstar Hospital, Antalya, Turkey.
  • Paydas S; Department of Internal Medicine, Division of Medical Oncology, Cukurova University, Adana, Turkey.
  • Özdemir E; Department of Oncology, Medicana International Hospital, Ankara, Turkey.
  • Yildiz B; Department of Internal Medicine, Division of Medical Oncology, Gulhane Research and Training Hospital, Ankara, Turkey.
  • Karadurmus N; Department of Internal Medicine, Division of Medical Oncology, Gulhane Research and Training Hospital, Ankara, Turkey.
  • Kaynar L; Department of Internal Medicine, Division of Hematology, Erciyes University, Kayseri, Turkey.
  • Yagci M; Department of Internal Medicine, Division of Hematology, Gazi University, Ankara, Turkey.
  • Özkocaman V; Department of Internal Medicine, Division of Hematology, Uludag University, Bursa, Turkey.
  • Topçuoglu P; Department of Internal Medicine, Division of Hematology, Ankara University, Ankara, Turkey.
  • Özcan M; Department of Internal Medicine, Division of Hematology, Ankara University, Ankara, Turkey.
  • Birtas E; Division of Hematology, Anadolu Medical Center, Kocaeli, Turkey.
  • Göker H; Department of Internal Medicine, Division of Hematology, Hacettepe University, Ankara, Turkey.
  • Ferhanoglu B; Department of Hematology, Koc University School of Medicine and V.K.V. American Hospital, Istanbul, Turkey. bferhan@gmail.com.
Ann Hematol ; 99(2): 301-307, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31844933
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Trasplante de Células Madre / Brentuximab Vedotina Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Trasplante de Células Madre / Brentuximab Vedotina Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Turquía